Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor

Jürgen Wichmann(Roche (Switzerland)), Piergiorgio Pettazzoni(Roche (Switzerland))
Clinical Cancer Research
November 15, 2021
Cited by 20


Related Papers

No related papers found

Powered by citation graph analysis